Amylx Pharmaceuticals Inc vs Arqit Quantum Inc — how do they compare? Amylx Pharmaceuticals Inc trades at $23.96 (market cap $2.64B), while Arqit Quantum Inc trades at $24.3 (market cap $424.79M). The key difference: Amylx Pharmaceuticals Inc is far larger — about 6.2× Arqit Quantum Inc's market cap, and Amylx Pharmaceuticals Inc is trading nearer its 52-week high, Arqit Quantum Inc nearer its low. Which is the better fit depends on your goals.
| AMLX | ARQQ | |
|---|---|---|
Market Cap | $2.64B | $424.79M |
Sector | Health | Technology |
52-Week High | $24.19 | $58.27 |
52-Week Low | $7.82 | $11.78 |
Enterprise Value | $2.39B | $398.10M |
Trailing returns across standard periods
Latest headlines on both assets
Amylyx Pharmaceuticals is a biopharmaceutical firm focused on developing therapies for rare diseases. Its pipeline includes treatments for conditions like post-bariatric hypoglycemia and congenital hyperinsulinism.
Read more on AMLX →Arqit Quantum provides advanced cybersecurity software that uses symmetric key agreement technology. Its solutions protect networked devices and data against current and future cyber threats, including quantum attacks.
Read more on ARQQ →